| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ... Cell 161 (7), 1681-1696, 2015 | 2657 | 2015 |
| Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib JA Sosman, KB Kim, L Schuchter, R Gonzalez, AC Pavlick, JS Weber, ... New England Journal of Medicine 366 (8), 707-714, 2012 | 2564 | 2012 |
| Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial A Ribas, I Puzanov, R Dummer, D Schadendorf, O Hamid, C Robert, ... The lancet oncology 16 (8), 908-918, 2015 | 1754 | 2015 |
| Combined nivolumab and ipilimumab in melanoma metastatic to the brain HA Tawbi, PA Forsyth, A Algazi, O Hamid, FS Hodi, SJ Moschos, ... New England Journal of Medicine 379 (8), 722-730, 2018 | 1168 | 2018 |
| Leptin in immunology G Matarese, S Moschos, CS Mantzoros The Journal of Immunology 174 (6), 3137-3142, 2005 | 809 | 2005 |
| Leptin and reproduction: a review S Moschos, JL Chan, CS Mantzoros Fertility and sterility 77 (3), 433-444, 2002 | 783 | 2002 |
| Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial MA Davies, P Saiag, C Robert, JJ Grob, KT Flaherty, A Arance, ... The Lancet Oncology 18 (7), 863-873, 2017 | 705 | 2017 |
| The role of the IGF system in cancer: from basic to clinical studies and clinical applications SJ Moschos, CS Mantzoros Oncology 63 (4), 317-332, 2002 | 530 | 2002 |
| Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma K Trunzer, AC Pavlick, L Schuchter, R Gonzalez, GA McArthur, TE Hutson, ... Journal of clinical oncology 31 (14), 1767-1774, 2013 | 463 | 2013 |
| Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans CS Mantzoros, S Moschos, I Avramopoulos, V Kaklamani, A Liolios, ... The Journal of Clinical Endocrinology & Metabolism 82 (10), 3408-3413, 1997 | 420 | 1997 |
| Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays YL Tolstov, DV Pastrana, H Feng, JC Becker, FJ Jenkins, S Moschos, ... International journal of cancer 125 (6), 1250-1256, 2009 | 398 | 2009 |
| Leptin: in search of role (s) in human physiology and pathophysiology CS Mantzoros, SJ Moschos Clinical endocrinology 49 (5), 551-567, 1998 | 322 | 1998 |
| Neoadjuvant treatment of regional stage IIIB melanoma with high-dose interferon alfa-2b induces objective tumor regression in association with modulation of tumor infiltrating … SJ Moschos, HD Edington, SR Land, UN Rao, D Jukic, J Shipe-Spotloe, ... Journal of Clinical Oncology 24 (19), 3164-3171, 2006 | 299 | 2006 |
| Next generation of immunotherapy for melanoma JM Kirkwood, AA Tarhini, MC Panelli, SJ Moschos, HM Zarour, ... Journal of Clinical Oncology 26 (20), 3445-3455, 2008 | 276 | 2008 |
| Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: a systematic review and meta-analysis TF Nishijima, HB Muss, SS Shachar, SJ Moschos Cancer treatment reviews 45, 30-37, 2016 | 254 | 2016 |
| Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity DD Pierroz, M Ziotopoulou, L Ungsunan, S Moschos, JS Flier, ... Diabetes 51 (5), 1337-1345, 2002 | 254 | 2002 |
| PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines J Fourcade, Z Sun, O Pagliano, JM Chauvin, C Sander, B Janjic, ... Cancer research 74 (4), 1045-1055, 2014 | 237 | 2014 |
| Outcome predictors of Gamma Knife surgery for melanoma brain metastases DN Liew, H Kano, D Kondziolka, D Mathieu, A Niranjan, JC Flickinger, ... Journal of neurosurgery 114 (3), 769-779, 2011 | 213 | 2011 |
| Importance of glycolysis and oxidative phosphorylation in advanced melanoma J Ho, MB de Moura, Y Lin, G Vincent, S Thorne, LM Duncan, L Hui-Min, ... Molecular cancer 11, 1-13, 2012 | 171 | 2012 |
| Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label … HA Tawbi, PA Forsyth, FS Hodi, AP Algazi, O Hamid, CD Lao, ... The lancet oncology 22 (12), 1692-1704, 2021 | 170 | 2021 |
